arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

IGC Pharma, Inc.

IGC Health Care Biotechnology: Pharmaceutical Preparations
$0.25
▲ +3.8% Today
as of Oct 23, 10:03 ET
Last 30 days -11.00% Sep 14 → Oct 23
$0.24 $0.25 $0.26 $0.28 $0.29 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$0.24
High
$0.25
Low
$0.24
Volume
$174,941
Avg Vol
$770,821
Mkt Cap
$28M
P/E (TTM)
—
Beta
—
52w High
$0.45
52w Low
$0.24
Div Yield
—
Shares Out
$102M

Recent Press Releases & News last 60 days · 2 items

Oct 13 · 12:00 PR ACCESS Newswire
IGC Pharma Unveils PRISM AI Platform to Move Alzheimer's Risk Prediction to Brain-Health Action and Commercial Deployment
Sep 28 · 12:00 PR ACCESS Newswire
IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026

IGC earnings at a glance

The options market is pricing a move of about ±1607.7% after the report, a range of roughly -$3.77 to $4.27 from today's $0.25. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±1.7% on average; after the most recent report on May 15, 2026 it moved -3.3%. That means options currently expect more movement than IGC has typically delivered. IGC beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 136%. The share price of $0.25 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.24
$0.45
5% of range
Avg surprise (last 4)
+20.8%
Avg reaction (last 2)
-1.7%
0% positive
Latest IV / EM
13610%
EM ±1607.7% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.59$-0.32$-0.05$0.22$0.49 Actual $-0.08Actual $-0.05Actual $-0.09Actual $-0.03Actual $-0.02Actual $-0.02Actual $-0.02Actual $-0.01Est $-0.02Actual $-0.02Est $-0.03Actual $-0.02Est $-0.02Actual $-0.02Est $-0.02Actual $-0.03 Mar/2023SepDecJunSepDecMarMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-3M$-2M$-1M$-409,550$432,600 Sep 24Dec 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.03 — — — — financials
Fri May 15, 2026Mar/2026 $-0.02 $-0.02 0.0% — -3.3% earnings
Fri Nov 14, 2025Sep/2025 $-0.02 $-0.02 0.0% — — earnings
Thu Aug 14, 2025Jun/2025 $-0.02 $-0.03 +33.3% — — earnings
Fri Jun 27, 2025Mar/2025 $-0.01 $-0.02 +50.0% — 0.0% earnings
Mon Mar 31, 2025Mar 2025 $-0.02 — — — — financials
Tue Dec 31, 2024Dec 2024 $-0.02 — — — — financials
Mon Sep 30, 2024Sep 2024 $-0.02 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.03 — — — — financials
Sun Dec 31, 2023Dec 2023 $-0.09 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.05 — — — — financials
Fri Jul 7, 2023Mar/2023 $-0.08 — — — — earnings

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$265,000$317,000—$191,000$328,000$330,000$257,000$412,000
Cost of revenue$217,000$262,000—$92,000$174,000$176,000$153,000$214,000
Gross profit$48,000$55,000—$99,000$154,000$154,000$104,000$198,000
Operating income$-3M$-2M—$-3M$-2M$-1M$-2M$-2M
Net income$-3M$-2M—$-2M$-2M$-1M$-2M$-2M
EPS (diluted)$-0.03$-0.02—$-0.02$-0.02$-0.02$-0.02$-0.02

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$331,000$207,000$900,000$1M$454,000—$470,000$2M
Inventory$640,000$638,000$640,000$658,000$1M—$1M$2M
Total current assets$1M$1M$2M$2M$2M—$3M$4M
Total assets$9M$9M$10M$10M$8M—$9M$10M
Long-term debt———$132,000$133,000—$134,000$135,000
Total liabilities$3M$3M$2M$2M$2M—$3M$3M
Total equity$6M$6M$7M$8M$6M$6M$6M$7M

Implied volatility — last 90 days

702%3947%7192%10437%13682% Jun 07 — IV 1515% · EM ±209.8%Jun 08 — IV 1265% · EM ±167.0%Jun 10 — IV 1356% · EM ±160.1%Jun 11 — IV 1571% · EM ±173.6%Jun 12 — IV 1571% · EM ±160.7%Jun 17 — IV 4576% · EM ±191.1%Jun 19 — IV 988% · EM ±218.3%Jun 22 — IV 898% · EM ±187.5%Jun 23 — IV 1147% · EM ±234.7%Jun 24 — IV 1016% · EM ±203.4%Jun 25 — IV 1072% · EM ±210.0%Jun 26 — IV 1163% · EM ±222.6%Jun 30 — IV 1159% · EM ±199.6%Jul 01 — IV 1307% · EM ±218.4%Jul 02 — IV 1351% · EM ±218.5%Jul 06 — IV 1542% · EM ±213.5%Jul 07 — IV 2315% · EM ±305.8%Jul 08 — IV 2289% · EM ±286.7%Jul 10 — IV 3161% · EM ±349.3%Jul 13 — IV 4277% · EM ±357.3%Jul 20 — IV 948% · EM ±224.0%Jul 21 — IV 957% · EM ±222.6%Jul 22 — IV 891% · EM ±203.9%Jul 23 — IV 755% · EM ±169.8%Jul 24 — IV 1011% · EM ±223.5%Jul 27 — IV 1093% · EM ±228.1%Jul 29 — IV 1340% · EM ±268.5%Jul 30 — IV 820% · EM ±160.6%Jul 31 — IV 1236% · EM ±236.6%Aug 03 — IV 1382% · EM ±244.8%Aug 04 — IV 1522% · EM ±262.1%Aug 05 — IV 1408% · EM ±235.3%Aug 06 — IV 1608% · EM ±260.1%Aug 10 — IV 1919% · EM ±265.8%Aug 11 — IV 1454% · EM ±192.0%Aug 12 — IV 1832% · EM ±229.5%Aug 13 — IV 2002% · EM ±236.5%Aug 14 — IV 2128% · EM ±235.1%Aug 17 — IV 3091% · EM ±258.2%Aug 18 — IV 2710% · EM ±196.0%Aug 19 — IV 2919% · EM ±172.4%Aug 20 — IV 4759% · EM ±198.8%Aug 24 — IV 797% · EM ±166.3%Aug 25 — IV 730% · EM ±149.5%Aug 26 — IV 1379% · EM ±276.2%Aug 27 — IV 703% · EM ±137.6%Aug 28 — IV 747% · EM ±142.9%Aug 31 — IV 755% · EM ±133.7%Sep 01 — IV 1751% · EM ±301.5%Sep 02 — IV 1720% · EM ±287.3%Sep 04 — IV 966% · EM ±151.0%Sep 07 — IV 1090% · EM ±151.0%Sep 08 — IV 1175% · EM ±155.2%Sep 09 — IV 1276% · EM ±159.9%Sep 10 — IV 1357% · EM ±160.3%Sep 11 — IV 1468% · EM ±162.2%Sep 14 — IV 2360% · EM ±197.1%Sep 17 — IV 6292% · EM ±262.8%Sep 21 — IV 7952% · EM ±1660.6%Sep 22 — IV 7623% · EM ±1559.7%Sep 23 — IV 7591% · EM ±1520.4%Sep 24 — IV 8082% · EM ±1583.1%Sep 25 — IV 8326% · EM ±1593.5%Sep 28 — IV 9269% · EM ±1642.3%Sep 29 — IV 9661% · EM ±1663.6%Sep 30 — IV 10018% · EM ±1673.5%Oct 01 — IV 10419% · EM ±1685.2%Oct 02 — IV 10569% · EM ±1651.5%Oct 06 — IV 11629% · EM ±1535.8%Oct 07 — IV 13683% · EM ±1714.3%Oct 08 — IV 13610% · EM ±1607.7%

Sector peers

CPHI
China Pharma Holdings, Inc.
$28M $0.66-6.4%
MCRB
Seres Therapeutics, Inc.
$27M $2.05-10.9%
CNTX
Context Therapeutics Inc.
$29M $0.22-3.2%
ABVC
ABVC Biopharma, Inc.
$27M $1.06+5.8%
KYNB
Kyntra Bio, Inc.
$26M $5.09-2.3%
NXTC
NextCure, Inc.
$30M $4.82-11.0%

IGC earnings FAQ

What is IGC's expected move for earnings?

Options currently price a move of about ±1607.7%, or $4.02 per share either way from $0.25.

How does IGC stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.7%, up 0 times and down 2 times.

What is IGC's implied volatility?

IGC's at-the-money implied volatility is about 136% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in